OBJECTIVES: We studied the effect of antiretroviral therapy (ART) on the quality of life (QOL) of Cubans with HIV/AIDS. METHODS: We conducted a cross-sectional study including administration of the Medical Outcomes Study-HIV Health Survey Questionnaire to a representative sample of the 1592 Cubans receiving ART in 2004. For univariate analyses, we compared mean HIV scale scores. We used logistic regression models to estimate the association between role function and year of diagnosis, between pain and sex, and between health transition and region of diagnosis, with adjustment for demographics, ART regimen, and clinical status. RESULTS: There were 354 participants (73 women, 281 men). Scores for all functional activities showed means higher than 80 out of 100. Pain interfered more in women than in men (73.2 vs 81.9; P = .01). When HIV diagnosis occurred after 2001, the probability of experiencing difficulties performing work (odds ratio [OR] = 4.42; 95% CI = 1.83, 10.73) and pain (OR = 1.70; 95% CI = 1.01, 2.88) increased compared with earlier diagnosis. People treated with indinavir showed a greater perception of general health (58.9 vs 52.4; P = .045) and greater health improvement (78.6 vs 67.8; P = .002). CONCLUSIONS: Although Cubans receiving ART are maintaining a high QOL, we observed significant differences by sex and time of diagnosis. QOL assessment can serve as a health outcome and may allow identification of QOL reductions potentially related to ART side effects.
OBJECTIVES: We studied the effect of antiretroviral therapy (ART) on the quality of life (QOL) of Cubans with HIV/AIDS. METHODS: We conducted a cross-sectional study including administration of the Medical Outcomes Study-HIV Health Survey Questionnaire to a representative sample of the 1592 Cubans receiving ART in 2004. For univariate analyses, we compared mean HIV scale scores. We used logistic regression models to estimate the association between role function and year of diagnosis, between pain and sex, and between health transition and region of diagnosis, with adjustment for demographics, ART regimen, and clinical status. RESULTS: There were 354 participants (73 women, 281 men). Scores for all functional activities showed means higher than 80 out of 100. Pain interfered more in women than in men (73.2 vs 81.9; P = .01). When HIV diagnosis occurred after 2001, the probability of experiencing difficulties performing work (odds ratio [OR] = 4.42; 95% CI = 1.83, 10.73) and pain (OR = 1.70; 95% CI = 1.01, 2.88) increased compared with earlier diagnosis. People treated with indinavir showed a greater perception of general health (58.9 vs 52.4; P = .045) and greater health improvement (78.6 vs 67.8; P = .002). CONCLUSIONS: Although Cubans receiving ART are maintaining a high QOL, we observed significant differences by sex and time of diagnosis. QOL assessment can serve as a health outcome and may allow identification of QOL reductions potentially related to ART side effects.
Authors: Denise M Gaughan; Michael D Hughes; George R Seage; Peter A Selwyn; Vincent J Carey; Steven L Gortmaker; James M Oleske Journal: Pediatrics Date: 2002-06 Impact factor: 7.124
Authors: Carmina R Fumaz; Albert Tuldrà; Ma José Ferrer; Roger Paredes; Anna Bonjoch; Toni Jou; Eugènia Negredo; Joan Romeu; Guillem Sirera; Cristina Tural; Bonaventura Clotet Journal: J Acquir Immune Defic Syndr Date: 2002-03-01 Impact factor: 3.731
Authors: Nicholas I Paton; Chere A T Chapman; Siew-Pang Chan; Karen M Tan; Yee-Sin Leo; Jamila Aboulhab; Chang-Heok Soh Journal: Int J STD AIDS Date: 2002-07 Impact factor: 1.359
Authors: Christopher J Gill; John L Griffith; Denise Jacobson; Sarah Skinner; Sherwood L Gorbach; Ira B Wilson Journal: J Acquir Immune Defic Syndr Date: 2002-08-15 Impact factor: 3.731